Baltbear on Finance markets are like marshmallows

elsewhere a few boiler room employees and random people who do not yet understand that “the stock doesn’t know you own it”– peter lynch’s classic paraphrase of the principal of insufficient reason–have been paraphrasing my thoughts about the plan by which btiotime (btim.ob) stays in business.

these hypesters maintain that i said biotime (btim.ob) has no business plan. that’s not anything i have ever said at all. but then hypesters exist to push the greed inverse of fud.

so, for the “record”, here is the summary of biotime’s nusainess plan from inception to now, with michael west, the “stem cell guy” at the purported helm, although al (outboard al, twa al, bethlehem steel kingsley) is actually now running the shoppe.

i have never sad that btim has no bizness plan.

the plan, according to btim, as stated in its filings is:

1. license patent estates and repackage them; (being done)
2. license software  for the building of a clearing house for stem cell info; (done);
3. develop a line of reagents and tools for biomedical research (in progress)
4. sell stock to fund the inner circle (being done more and more)
5. use the buzz to get listed on nasd or..lol..amex… (in progress)
6. hire boiler rooms to pump (done regularly);
7. increase financiers’ net $$ and % without risk (every year since 96)
8. sell stem cells (been being done for over a year without report of any sales)
9. cash checks from hextend license and distribute to financiers  to keep the door open,(done every year from 2000 to april this year);
10. get grants, and do work once the $$ are in hand; (limited success with hextend (<$1mm since 2000, studies evidently failed since there was no follow up) $1.6mm a year for 3 years offered by california for stem cells. six month after grant authorised, no reports of money received, but a statement from btim that with $4mm in the bank thy will do no work on th grant project til cash in hand, even tho the grant is for the core of their held-out biz strategy.
11. spin off “subsidiaries) that allow the financers to profit w/o very low risk;
12. use warrants as a play pretty to manipulate the borrow and bring in cash to the treasury (maybe 5 or 6 times in 12 years);
13. paint the tape.

how well is this plan working??
for those who like the story and understand this puppy is about 1% as solid as fnm, i’d suggest a tonne of limit orders ~4, and get out anywhere north of 5 that makes you happy.
that’s 25%. or, if u really like this puppy, open up the limits in a widening ram from 4 7/16, and taper i out over 5 1/4… for 25% plus some free shares.
…since that’s what the players here have been doing since… hmmm…. ‘96???
what was it that happened in 96? that’s about when biotime started paying al kingsley for “advice.”

Posted under business

someone suggested to me that i was paid to bash biotime (btim.ob). i replied that the paid bashing on the net was being done by steven seinberg, chief financial officer (cfo) of biotime, in posts to the securities and exchange commission.  it is of interest possibly to note that  some anonymous person publicly stated a day or 4 ago that biotime was about to receive a $5mm grant.  That’s the kind of world where bucket shops and boiler rooms thrive: people doing honest analysis must be “paid bashers” while people doing mindless and dishonest cheerleading to protect teir positions are considered “loyal shareholders.”
here’s an example f what i mean:

the 8k filed on 0417 describing what happened on 0415:

The maturity date of our Revolving Line of Credit has been extended to December 1, 2009 with respect to $2,669,282 in principal amount of loans. (a revolving line of credit for $2.669mm got a new date, 7 1/2 month away.)

“We repaid $223,834 of principal and accrued interest on loans that matured on April 15, 2009 and were not extended.
(some part of the credit line was shut off, and paid out. does biotime bother to be honest enough to say which part?)

” In addition, certain lenders exercised their right to exchange $572,404 of principal and accrued interest on loans for an aggregate of 473,131 of our common shares.”
Does biotime bother to say how much of the $572k was principal and how much interest?  some loans were at 12%.
if one speculates that 12% is the figure, and 1 year the time period, then the lender lost oportunity for 1 year on apx $511k, and then was traded for 473k shares, for a basis of 1 3/32 ish…. ($1.08).
And actually, its worse than that. How??
becuase, to use a term from aother world, biotime had to pay vigourish on the loan. it was forced to give for free  91,526 shares, based on a 6% iterest rate, to the lenders.
91,526 is therefore 6% of what? 6% of the $2mm comes to $160,156. and that converts to 91,256 shares how? on a basis of 1 3/4 ($1.75 a share).
does this sound like an invented number?
biotime identifies this number:
“Promissory notes that were exchangeable for our common shares at a price of $1.50 and Embryome Sciences common stock at $2.50 until April 15, 2009, may now be exchanged for our common shares at $1.75 per share”
and i offer that as evidence of the soundness of this analysis.

a coupl;e of days later 14ds were filed with the sec, and the movement from the dtc to the recipients had to cross the tape. it crossed it at prevailing prices f the moment, cuasing some to see a “rally” which they traded into and or out of.
However, the idea that the buyers actually paid anything more than is stated above is a fiction.
Biotime would, imho, have a moral and fiduciary duty to identify it as a fiction.
Did it?
ask the reporters who called (or were they called??) what the ceo, dr michael west said.
then the prudent speculator has a metric for the integrity of the “science” of biotime.

the “good news” in this 8 k is that the exchange price isn;t 16 cents.
the hoest news is that this is the 5th amendment to a credit agreement that is nowhere near being retired, and there is no evidence in the 10k as to how it ever will be.
bottom line?
people buying biotime stock are not buying equity in biotime, bcuase there is no equity except patents 1/2 way thru their life.  they are supporting the acquisition of biotime by al kingsley and neal bradshear, who are paying next to nothing for it.

” We may borrow up to an additional $830,718 under our revolving line of credit if we elect to do so and are able to obtain additional loan commitments from our current lender or from new lenders.”

notice how bio time cannot, unnder thee covenenants borrow $1 mm from somebody new.
notice how biotime evidently needs permission from the current creditors to eve look for financing, up to the $830 mark.

Posted under business

The prudent speculator will generally listen to what management states as goals.
Somwhere in the s3 there will be something about “we intend to make widgets. there are already widgets out there, and so we may not succeed. we expect to succeed because we have a new way to make widgets.”

Under sec law, random people may attempt to raise a $million under a 504, which functionally only needs to state the goals of raising a mil for some purpose to be later identified.

Generally, people become medical doctors to practice medicine, and people get nasdaq licenses in order to move stock on the nasdaq.

Interestingly enough, as part of the cloning/stemcell/corpsicle, infuse groundgog genes into the brain thinking of the collateral group around dr west of biotime, there is another hybrid:

:”One of the main goals this year for West is to get BioTime traded on either the American or Nasdaq stock exchange.”

http://www.insidebayarea.com/business/ci_12211685

The prudent speculator might think the main goals of a deeply in the hole biotec would be to develop product and revenue stream. That’s one of those antique ben graham ideas that the modern trader knows to avoid. the goal of a development stage biotech is to sell stock, even if it’s been a development stage company for 17 years; actually, especially then.

The prudent speculator might think that a ceo who doesn’t clarify for the press that a “purchase” of shares recorded in a 14d was actually the registration of shares granted as a penalty for failure to meet loan covenants, and as a result as at a basis of 0.

The prudent speculator might think that when the ceo, dr. west, states that
“We’re optimistic that we’re going to be handsomely profitable in a short while,” and is talking about a company that was required to tell the sec in a 10k that if it didn’t refinance debt and obtain further on april 15, it would not be able to continue operations, and told the sec in an 8k on april 17th that its net credit lines had not fundamentally changed, and had had to issue free stock as a penalty, that the “handsome profits” come from selling stock, not from doing biotech product development, especially if said cmpany had once before had a board member (ron barkin, former attorney) publicly state earnings estimates based on a mix if sheer fantasy (instant full market acceptance for off label use) that would be priced in violation of fda guidelines concerning pricing equivalent product.
barkin was gone shortly after that.
how much longer will dr. west and his secrets of immortiality be hanging aorund alameda?

Posted under business

According to biotime sec filings (btim.ob)

:”Current loans under the Credit Agreement bear interest at the rate of 12% per annum and will mature on April 15, 2009, at which time the outstanding principal balance of the loans plus accrued interest will be due and payable. Our ability to continue in operation depends on our obtaining a renewal of the Credit Agreement that will extend the maturity date of the loan and increase the amount of credit available to us.”

so, it is now april 16th. yesterday, the market reacted intelligently to the known facts (thew ones that deny the nonsense of obama= stem cells = west = btim biotime = $$$).

let’s compare this puppy to the largest commercial real estate fir in the usa:
:”"When we did not achieve the necessary amount of agreement on the bond solicitation, at that point we recognized that it was conceivable that we would not get the time outside of bankruptcy that we had hoped for to work on a restructuring,” General Growth President Thomas Nolan told Reuters.”

has biotime bothered to tell the 4500 or so shareholder anything about , generically, “how it’s going” ?
well. no.
that woiuld be silly.
they got the shareholders money. well, no..they didn’t.
the insiders got the shareholders $$$ by being able to short an open box; thereby regaining their risk capital and absorbing, steadily, all of the financioal advantage.
wo else benefits?
let’s go back to the mall bankruptcy:
:”"We will see a significant rise in delinquent and defaulted mortgages in commercial real estate above and beyond what we already experienced,” said Sam Chandan, president and chief economist at research firm Real Estate Economics”
this is something that might be less true in the swams near san francisco where biotime shareholders have spent a largish amount of money in a locked lease that contrbutes to real estate profits, not bodily health.

a fast look at an overly simple 5 day chart gives some clues:
http://finance.yahoo.com/q/bc?s=BTIM.OB&t=5d&l=on&z=m&q=l&c=

imho the fact that btiome could not successfully publish to the sec and the public the reults of the negotiations which it stated must be completed by april 15
says that biotime is playing a losuing hand and willfully misrepresenting itself to the “investor” who will fall for the pitch.
the prudent speculator will require some transparency, and stay away until that transparency is present.

Posted under business

here are the highlights of the 10k–which came out amazingly “early”. of course that can have nothing to do with my woofing about the biotime habit of waiting til the last minute.
The number of common shares outstanding as of February 26, 2009 was 25,213,569
that’s a 3 million share increase.
“As of March 10, 2009, there were 6,676 holders of the common shares”
was that increase in authorised discussed at the last annual meeting?
when was the last annual meeting?
“We intend to submit that amendment to our shareholders for approval at our next annual meeting.”
:” Management’s report was not subject to attestation by our registered public accounting firm pursuant to temporary rules of the Securities and Exchange Commission that permit us to provide only management’s report in this annual report.”
lolol…
for thoughts on accounting and filing with the sec, see
http://baltbear-on-finance.com/stock-market-speculating-is-a-hold-up-shoot-them-with-x-barrels

and  lookie lookie…some amusing info about “big al’s basis”. wunderbar:
:”We paid Greenbelt $90,000 in cash and issued 200,000 common shares for services rendered for the twelve months ending March 31, 2007.  Greenbelt permitted us to defer until October 2007 paying certain cash fees that otherwise would have been payable earlier in the year.  In return for allowing the deferral, we issued Greenbelt an additional 60,000 common shares.  For the 2008 calendar year, we agreed to pay Greenbelt $135,000 in cash and to issue 300,000 common shares.  Greenbelt permitted us to defer paying the entire $135,000 cash fee until January 2009.  In return for allowing the deferral, we issued Greenbelt an additional 60,000 common shares during January 2009.  We have agreed to file a registration statement, at our expense, to register Greenbelt’s shares for sale under the Securities Act of 1933, as amended, upon Greenbelt’s request.  We also agreed to indemnify Greenbelt and its officers, affiliates, employees, agents, assignees, and controlling person from any liabilities arising out of or in connection with actions taken on our behalf under the agreement.

ok, 620k share at a basis of…..zero.
zero.

and: $225,000 in cash.
so, here’s the algebra problem:
a train leaves the nasdaq at 9:30 in the morning with 620k shares which can be sold at any price at all, and bought back at any price less than sold for;
a train leaves park avenue with $225k cash
to buy stock at any price and sell it for any amount more than was paid for;
what is big al’s  basis?
the answer?? 0 on more and more of the shares in his control+ 9% profit after trip tickets are paid for+ $225,000 in cash.
extra credit question:
if late comers to biotime should have to pay 4x more than al pays, what should be their basis?

Since inception, we have primarily financed our operations through the sale of equity securities, licensing fees, royalties on product sales by our licensees, and borrowings.

our total research and development expenditures were approximately $1,700,000 and our administrative expenditures were approximately $2,600,000.
The Credit Agreement permits us to borrow up to $3,500,000, and as of March 6, 2009, BioTime had outstanding Credit Agreement loans of $3,330,000.

Current loans under the Credit Agreement bear interest at the rate of 12% per annum and will mature on April 15, 2009, at which time the outstanding principal balance of the loans plus accrued interest will be due and payable.

Currently, lenders may exchange their notes for our common shares at prices ranging from $1.25 to $1.50 per share,

and our ability to commence and complete the clinical trials that are required in order for us to obtain FDA and foreign regulatory approval of products, depend upon the amount of money we have.

so, taking “big al” lol..out of th equation, what is there for fair market price in the opinion of those who have access to serious due diligence???
1 1/4–1 1/2 ….divided by 1.12.

hmmmm.
that put’s a price amusingly close to 1 3/8..which got defended as a raw marker…
and verrry close to 1 5/32….right where the defense kicked in.

so, those who see that hextend >>>works<<< and give a dang aobut that;
who see that hetacool therefore >>might work<<;
who think that “dr west” matters one way or the other;
and who can overlook an over 20 year trip to the gorss receipts level, and overlook the r&d/g&a of this puppy;
now know what price to pay.
there are 2 ways to pay it:
call them up and ask when they are getting ready for the next level of dilution (which is alread oocurring by seling embryome stock)
or trade this puppy into accumulation s that u end up with shares closer to “big al’s” basis.
so..what is big al’s basis???

anybody notice what this burst of news, did for volume?? 9k thru 2 pm…another 7k tossed back and forth in the last 30 minutes to to create illusion?
http://finance.yahoo.com/echarts?s=BTIM.OB#chart2:symbol=btim.ob;range=1d;indicator=bollinger+ema(20,50,10)+psar+ke_it+volume+rsi+volumema(10);charttype=candlestick;crosshair=on;ohlcvalues=0;logscale=off;source=undefined
anybody notice that the whole “sector” as a “story” play now rests on the spines of 8 rats?

Posted under finance

This is a general piece for the prudent speculator. It is about a tool for measuring, at an amotional level some cold hard facts ypou are going to need.
A little history:
once upon a time when the people who said this liquidity crisis couldn’t happn hadn’t been born yet, every 3 months publicly traded corporations wrote up dozens to hundreds of pages of impenetrable beancounter language and sent it to the sec as “proof” of something.
Then, eventuallly, the sec said it would no longer accept “the dog ate my homework”, “10k? the mailmain must have lost it”.
(if an adult reader doesn’t think this kind of excuse is till being made, i offr the 10q of biotime, btim:obb which contains the statement that becuse creditors of the self-styled stem cell research company are in different parts of the country, it took an extra time period to give an honest statement of the debt. some weeks later biotime filed, and the debt had been restructured in a d/e swap showing a clearing price of $1. )
the sec said that a transparent and liquid market is the goal of regulation, and thus mandated electronic filing of text files with readable data.
in just a few years the sec got around to noting that the .txt files could be made almost unreadable by human beings, and that the goal of regulation is a transparent and liquid market. thus, filins in .html became required. (this gives a file that opens from the sec website through your browser window, and then “reads” like a piece of paper.)
as an example:
compare the effort of reading
http://sec.gov/Archives/edgar/data/876343/000091957409002146/d964196_13d-a.htm
with
http://sec.gov/Archives/edgar/data/876343/000095000502000064/p14825_s3a.txt

A while ago, the securities and exchange commission got serious about the idea that actually, since relational databases and accessing data from them has been around for 50 years, they might have value for thw actual owners of a corporation–the people that hire management that then thinks it is the ownership–and potential owners have a right to not read, but actually understand what the filings say, as internally consistent documents.
since lotus notes, excel spread seets etc had been around for about 25 years, average people could find the relationships that had meaning to them.
since in about 1998 there had been serious work done, in part by tim berners lee, to find algorithms which would describe relationship between relationships seen by others, there could be an extensible markup language….xml..
CAn you see a thought emerging in the pea in the brontosauric sec’s head yet?
can you begin to imagine that since adobe acrobat has been capable of making a .pdf that contains pictures, movies, music–a complete little “website” all in one document, secure and shippable and readable, for >>>4 years<<< that corporations wishing te trust and money of the american people could be obliged to make the critical elements inside their filings “clickable” so that people could jump through them making sure there was honesty in them?
thus, there came, after lots of “pick me” “can i buy your congressman a nice plane ride” ? etc… a defined “extensible business relational language.”
xbrl.
an sec filing in xbrl is as searchable as this blog.
and any prudent speculator deserves one.
looking at some new ticker? wanting to get a feel for what your dd can get you?
call investor relations and ask them abot xbrl. if the answer is “we’ll do it as soon as we wil be kicked off the exchanges if we don’t” no matter how that is phrased, walk.
away.
the phrasing can be tricky. recently i was told by one posssible whore to dance with that management was far too involved in creating new products to hace paid much attention to another burdensome government regulation. i’ll never get near that puppy, becuase i never short.
i was told by another that they are looking forward to providing xbrl docs to the sec, because it will reduce calls to i/r to only those that point the company to ever more transparent means of presentation.
in reality, most tickers that speculators can work from are not your friends. they see you as fruit to be smashed to give them the juice to party on.
with this knowledge in hand, you can rob them of the secrets of their failures, double speaks, waste, hype, etc, by taking an x-barreled shotgun to their filings.
if they don;t want you to have that weapon, they are not your friends.

Posted under business